PRECISION PROTEOMICS

Precision Proteomics Inc. (PPI) is a biotechnology company commercializing a novel proteomics platform for basic, pre-clinical, and clinical research and for the development of next-generation precision medicine research. PPI's patented technology - including the SH2 Supberbinder (SH2S)- enables cutting-edge proteomics to serve the needs of our customers and collaborators in research, development, and clinical utilization of therapeutics. PPI's technology can systematically and quantitatively profile activations of key signal pathways and regulatory networks that drive pathogenesis or the development of resistance to therapy.

Also known as: Precision Proteomics Inc.

Primary location: London Canada